Discriminating among degenerative parkinsonisms using advanced 123I-ioflupane SPECT analyses

Discriminating among degenerative parkinsonisms using advanced 123I-ioflupane SPECT analyses

123I-ioflupane single photon emission computed tomography (SPECT) is a sensitive and well established imaging tool in Parkinson's disease (PD) and atypical parkinsonian syndromes (APS), yet a discrimination between PD and APS has been considered inconsistent at least based on visual inspection...

Full description

Bibliographic Details
Main Authors:	Simon Badoud, Dimitri Van De Ville, Nicolas Nicastro, Valentina Garibotto, Pierre R. Burkhard, Sven Haller
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Series:	NeuroImage: Clinical
Subjects:	Parkinson's disease Atypical parkinsonism Single photon emission computed tomography (SPECT) Multi vector pattern analysis (MVPA)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158216301231

Similar Items

Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
by: Nicolas Nicastro, et al.
Published: (2020-05-01)

Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
by: Diego Castillo-Barnes, et al.
Published: (2018-08-01)

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of 123I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
by: Hidetomo Murakami, et al.
Published: (2018-12-01)

Using Artificial Neural Network to Discriminate Parkinson’s Disease from Other Parkinsonisms by Focusing on Putamen of Dopamine Transporter SPECT Images
by: Chung-Yao Chien, et al.
Published: (2020-12-01)

Interpreting 123I–ioflupane dopamine transporter scans using hybrid scores
by: Kenneth J. Nichols, et al.
Published: (2018-05-01)

Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
by: Hidetomo Murakami, et al.
Published: (2017-09-01)

Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?
by: Stéphane Prange, et al.
Published: (2022-08-01)

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
by: Usman Saeed, et al.
Published: (2017-03-01)

Neuroimagem do transportador de dopamina na doença de Parkinson: primeiro estudo com [99mTc]-TRODAT-1 e SPECT no Brasil Neuroimaging of the dopamine transporter in Parkinson’s disease: first study using [99mTc]-TRODAT-1 and SPECT in Brazil
by: Ming Chi Shih, et al.
Published: (2006-09-01)

Improvement of diagnostic accuracy of Parkinson's disease on I-123-ioflupane single photon emission computed tomography (123I FP-CIT SPECT) using new Japanese normal database
by: Takao Kanzaki, et al.
Published: (2020-07-01)

The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)
by: Piotr Alster, et al.
Published: (2022-02-01)

Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [<sup>123</sup>I]FP-CIT SPECT/CT Brain Imaging
by: Jeanne P. Vu, et al.
Published: (2021-03-01)

NEUROIMÁGENES EN ENFERMEDAD DE PARKINSON: ROL DE LA RESONANCIA MAGNÉTICA, EL SPECT Y EL PET
by: Dr. Carlos Juri C., et al.
Published: (2016-05-01)

Atypical Parkinsonism: Methamphetamine may play a role
by: Mehri Salari, et al.
Published: (2022-05-01)

Vascular parkinsonism: A review on management updates
by: Thilini B Udagedara, et al.
Published: (2019-01-01)

Convolutional Neural Network-Based Parkinson Disease Classification Using SPECT Imaging Data
by: Jigna Hathaliya, et al.
Published: (2022-07-01)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of 123I-Ioflupane SPECT: an investigation of parkinsonian syndromes
by: Yu Iwabuchi, et al.
Published: (2019-09-01)

Psychosis in parkinsonism: an unorthodox approach
by: Onofrj M, et al.
Published: (2017-05-01)

Classification of the Multiple Stages of Parkinson’s Disease by a Deep Convolution Neural Network Based on <sup>99m</sup>Tc-TRODAT-1 SPECT Images
by: Shih-Yen Hsu, et al.
Published: (2020-10-01)

Machine Learning for Early Parkinson’s Disease Identification within SWEDD Group Using Clinical and DaTSCAN SPECT Imaging Features
by: Hajer Khachnaoui, et al.
Published: (2022-04-01)

Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies
by: Alice Martini, et al.
Published: (2018-12-01)

Atypical parkinsonism. Lecture
by: V. L. Golubev
Published: (2015-12-01)

TARDBP mutations in a cohort of Italian patients with Parkinson’s disease and atypical parkinsonisms
by: Cinzia Tiloca, et al.
Published: (2022-09-01)

Safety, biodistribution and radiation dosimetry of [123I]ioflupane in healthy Chinese volunteers
by: Min Zhang, et al.
Published: (2023-04-01)

Atypical parkinsonism and self‐mutilation: A new lens on the old concept
by: Mehri Salari, et al.
Published: (2021-11-01)

Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders
by: Renata Kowalska‐Taczanowska, et al.
Published: (2020-08-01)

Distinctive clinical and imaging trajectories in SWEDD and Parkinson’s disease patients
by: Cecilia Boccalini, et al.
Published: (2024-01-01)

Neurovestibular Dysfunction and Falls in Parkinson's Disease and Atypical Parkinsonism: A Prospective 1 Year Follow-Up Study
by: Jeroen Venhovens, et al.
Published: (2020-10-01)

Atypical parkinsonism can be a presenting feature of late‐onset Huntington's disease
by: Mehri Salari, et al.
Published: (2022-07-01)

Enhanced Parkinson’s Disease Diagnosis Through Convolutional Neural Network Models Applied to SPECT DaTSCAN Images
by: Hajer Khachnaoui, et al.
Published: (2023-01-01)

The role of SPECT-DaTSCAN in the diagnosis of isolated tremor syndromes
by: Agata Gajos, et al.
Published: (2018-10-01)

Pharmacological Management of insomnia Associated with Parkinson’s Disease
by: O. Vasiliu
Published: (2022-06-01)

If Not Insulin Resistance so What? – Comparison of Fasting Glycemia in Idiopathic Parkinson’s Disease and Atypical Parkinsonism
by: Chmiela T, et al.
Published: (2022-05-01)

Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
by: Arman Rahmim, et al.
Published: (2016-01-01)

Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism
by: Anouke van Rumund, et al.
Published: (2018-05-01)

CT-based attenuation correction in I-123-ioflupane SPECT.
by: Catharina Lange, et al.
Published: (2014-01-01)

The role of molecular imaging in assessing degenerative parkinsonism – an updated review
by: Nicolas Nicastro, et al.
Published: (2018-04-01)

Identifying and distinguishing of essential tremor and Parkinson’s disease with grouped stability analysis based on searchlight-based MVPA
by: FuChao Cheng, et al.
Published: (2022-11-01)

Atypical parkinsonian syndromes in a North African tertiary referral center
by: Amina Nasri, et al.
Published: (2021-01-01)

Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
by: Susanna Jakobson Mo, et al.
Published: (2018-11-01)